Extension of the intensive phase reduces unfavourable outcomes with the 8-month thioacetazone regimen

A Van Deun, KJM Aung, A Hamid Salim, MA Ali, MS Naha, PK Das, MA Hossain, E Declercq

    Research output: Contribution to journalA1: Web of Science-articlepeer-review

    Original languageEnglish
    JournalInternational Journal of Tuberculosis and Lung Disease
    Issue number11
    Pages (from-to)1255-1261
    Publication statusPublished - 2006


    • B780-tropical-medicine
    • Bacterial diseases
    • Tuberculosis
    • Drug therapy
    • Antimicrobial agents
    • Thioacetazone
    • Regimens
    • Treatment failure
    • Relapses
    • Bangladesh
    • Asia-South

    Cite this